A dominant-negative mutation of the growth hormone receptor causes familial short stature

This publication has 17 references indexed in Scilit:

• A Short Isoform of the Human Growth Hormone Receptor Functions as a Dominant Negative Inhibitor of the Full-Length Receptor and Generates Large Amounts of Binding Protein
  Molecular Endocrinology, 1997
• Alternatively spliced forms in the cytoplasmic domain of the human growth hormone (GH) receptor regulate its ability to generate a soluble GH-binding protein.
  Proceedings of the National Academy of Sciences, 1996
• Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor
  Molecular Endocrinology, 1996
• The proline-rich region of the GH receptor is essential for JAK2 phosphorylation, activation of cell proliferation, and gene transcription
  Molecular Endocrinology, 1995
• Mutations of the Growth Hormone Receptor in Children with Idiopathic Short Stature
  New England Journal of Medicine, 1995
• Identification of Phenylalanine 346 in the Rat Growth Hormone Receptor as Being Critical for Ligand-mediated Internalization and Down-regulation
  Published by Elsevier ,1995
• Growth hormone (GH) insensitivity due to primary GH receptor deficiency
  Endocrine Reviews, 1994
• A dominant negative erythropoietin (EPO) receptor inhibits EPO-dependent growth and blocks F-gp55-dependent transformation.
  Molecular and Cellular Biology, 1994
• Evidence for generation of the growth hormone-binding protein through proteolysis of the growth hormone membrane receptor
  Endocrinology, 1993
• Growth hormone receptor and serum binding protein: purification, cloning and expression
  Nature, 1987